Bristol Myers Squibb has announced that the FDA has given approval to label updates for Breyanzi and Abecma to treat multiple ...

AI has been a buzzword in the pharmaceutical industry for almost a decade, with countless headlines promising to ...

Porton Advanced Solutions and EVA Pharma have signed an MoU to enhance the development capabilities for CAR T-cell therapies.

The collaboration, set to begin on 1 July, will see Novo Nordisk team up with the telehealth company to offer Wegovy to ...

I’m in London, and I just paid for this damn fat drug I take. I said, it’s not working. They said, he said, I just paid $88 ...

Theravance Biopharma’s partner Viatris has received China's NMPA approval for Yupelri inhalation solution for maintenance treatment of COPD.

The CDE of China's NMPA has granted BioCity's endothelin receptor type A (ETA) antagonist, SC0062, a second BTD.

While the UK continues its close 25-year partnership with Gavi, the US is halting funding to the organisation. In a move that ...

Equipped with a new CEO, Vor Bio is transitioning into an autoimmune player, leaving cell and gene therapy behind.

The US FDA has granted approval for a label update to Eli Lilly and Company's Amyvid (florbetapir F 18 injection) for use ...

Novartis has completed its previously announced acquisition of Regulus Therapeutics for $1.7bn, strengthening its renal ...

Drug discovery has traditionally been slow, expensive and prone to failure, but AI and machine learning are set to change all ...